TG Therapeutics Inc (TGTX)
Healthcare
Biotechnology
52.00 $
-2.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns TG Therapeutics Inc (TGTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.3% of the shares are freely tradable; institutional investors hold 70.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
70.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
7.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
88.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
28.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
153Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 14.54 | 22,252,930 | +1.9 | 03/31/2026 |
| Vanguard Group Inc | 10.35 | 15,841,002 | +2.1 | 12/31/2025 |
| State Street Corp | 5.65 | 8,649,766 | +2.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.40 | 8,273,979 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.31 | 6,603,258 | +0.0 | 03/31/2026 |
| Soleus Capital Management, L.P. | 2.63 | 4,029,319 | +28.4 | 03/31/2026 |
| Geode Capital Management, LLC | 2.29 | 3,499,916 | +2.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.39 | 8,248,882 | +0.0 | 05/29/2026 |
| Vanguard Total Stock Mkt Idx Inv | 3.16 | 4,833,466 | +0.3 | 04/30/2026 |
| Vanguard Small Cap Index | 2.27 | 3,475,676 | -0.2 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.